| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 766920 | 87920 | VENLAFAXINA RETARD TEVA-RATIOPHARM 75 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | VENLAFAXINA RETARD TEVA-RATIOPHARM 75 MG CAPSULAS DURAS DE LIBERACION PROLONGADA, 30 cápsulas (HDPE + tapón de rosca PP) | 75 mg | 6 | 30 | 43 | 30 cápsulas (HDPE + tapón de rosca PP) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/87920/87920_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/87920/87920_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2022-07-01 | 1 | 1 | 1 | 2022-07-02 | 2025-02-10 | 1 | 2026-02-15 | View Edit Delete | ||||||||||||
| 701926 | 78614 | TEICOPLANINA ACCORD 400 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | TEICOPLANINA ACCORD 400 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial (polvo) + 1 vial de disolvente | 400 mg | 45 | 1 | 34 | 1 vial (polvo) + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78614/78614_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78614/78614_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2014-04-01 | 1 | 1 | 1 | 2014-04-01 | 2014-04-01 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 727353 | 04304004IP4 | AZILECT 1 MG COMPRIMIDOS | AZILECT 1 MG COMPRIMIDOS, 30 comprimidos | 1 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04304004IP4/04304004IP4_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04304004IP4/04304004IP4_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | EUROMED PHARMA SPAIN S.L. | 2019-11-14 | 1 | 1 | 1 | 2019-11-15 | 2019-11-14 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 764903 | 89555 | EZETIMIBA/ATORVASTATINA SANDOZ FARMACÉUTICA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | EZETIMIBA/ATORVASTATINA SANDOZ FARMACÉUTICA 10 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 30 comprimidos | 40 mg/10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89555/89555_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89555/89555_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2024-06-03 | 1 | 1 | 1 | 2024-06-03 | 2024-06-03 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 765179 | 81952 | TADALAFILO SANDOZ 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TADALAFILO SANDOZ 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 8 comprimidos (PVC/PVDC/Al) | 20 mg | 5 | 8 | 10 | 8 comprimidos (PVC/PVDC/Al) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81952/81952_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81952/81952_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2017-04-10 | 1 | 1 | 1 | 2017-04-11 | 2024-06-18 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 765270 | 89668 | ERTAPENEM LORIEN 1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | ERTAPENEM LORIEN 1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 1.000 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89668/89668_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89668/89668_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29200 | LABORATORIOS LORIEN S.L. | 2025-02-05 | 1 | 1 | 1 | 2025-02-05 | 2025-02-05 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 765540 | 107427084 | OLANZAPINA TEVA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLANZAPINA TEVA 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 56 comprimidos | 10 mg | 110 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/107427084/107427084_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/107427084/107427084_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2024-08-02 | 1 | 1 | 1 | 2024-08-03 | 2024-08-02 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 766387 | 110614005 | MENVEO SOLUCION INYECTABLE | MENVEO SOLUCION INYECTABLE, 1 vial de 0,5 ml | N/A (vacuna) | 45 | 1 | 34 | 1 vial de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/110614005/110614005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/110614005/110614005_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19738 | GLAXOSMITHKLINE S.A. | 2024-11-29 | 1 | 1 | 1 | 2024-11-30 | 2024-11-29 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 766191 | 82586 | DEXMEDETOMIDINA EVER PHARMA 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | DEXMEDETOMIDINA EVER PHARMA 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 5 ampollas de 10 ml | 100 microgramos/ml inyectable perfusión 10 ml | 45 | 5 | 1 | 5 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82586/82586_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82586/82586_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 23345 | EVER PHARMA THERAPEUTICS SPAIN S.L. | 2018-03-22 | 1 | 1 | 1 | 2018-03-22 | 2024-11-08 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 768112 | 90449 | RISEDRONATO CINFAMED 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RISEDRONATO CINFAMED 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 2 comprimidos | 75 mg | 5 | 2 | 10 | 2 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90449/90449_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90449/90449_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2025-07-15 | 1 | 1 | 1 | 2025-07-16 | 2025-07-15 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 767102 | 1151066003IP2 | ONGENTYS 50 MG CAPSULAS DURAS | ONGENTYS 50 MG CAPSULAS DURAS, 30 cápsulas | 50 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151066003IP2/1151066003IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151066003IP2/1151066003IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9526 | EUROMED PHARMA SPAIN S.L. | 2025-03-04 | 1 | 1 | 1 | 2025-03-05 | 2025-03-04 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 768615 | 3135414C | LIPOCOMB 10 MG/10 MG CAPSULAS DURAS | LIPOCOMB 10 MG/10 MG CAPSULAS DURAS, 30 cápsulas | 10 mg/10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73098 | DIFARMED S.L.U. | 2025-10-01 | 1 | 1 | 1 | 2025-10-02 | 2025-10-01 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 768616 | 3135514CIP1 | LIPOCOMB 20 MG/10 MG CÁPSULAS DURAS | LIPOCOMB 20 MG/10 MG CÁPSULAS DURAS, 30 cápsulas | 20 mg/10 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73098 | DIFARMED S.L.U. | 2025-10-01 | 1 | 1 | 1 | 2025-10-02 | 2025-10-01 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 767990 | 113818008 | BOSULIF 50 MG CAPSULAS DURAS | BOSULIF 50 MG CAPSULAS DURAS, 30 cápsulas | 50 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113818008/113818008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113818008/113818008_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2025-06-23 | 1 | 1 | 1 | 2025-06-24 | 2025-06-23 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 767991 | 113818009 | BOSULIF 100 MG CAPSULAS DURAS | BOSULIF 100 MG CAPSULAS DURAS, 150 cápsulas | 100 mg | 6 | 150 | 58 | 150 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113818009/113818009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113818009/113818009_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2025-06-23 | 1 | 1 | 1 | 2025-06-24 | 2025-06-23 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 769362 | 08447003IP1 | ADENURIC 120 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ADENURIC 120 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (PVC/PE/PVDC/Alu) | 120 mg | 5 | 28 | 10 | 28 comprimidos (PVC/PE/PVDC/Alu) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08447003IP1/08447003IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08447003IP1/08447003IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2025-12-05 | 1 | 1 | 1 | 2025-12-06 | 2025-12-05 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 769551 | R1846IP | ZYRTEC 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ZYRTEC 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/R1846IP/R1846IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9966 | MELYFARMA S.L. | 2025-12-17 | 1 | 1 | 1 | 2025-12-18 | 2025-12-17 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 769610 | 24076IP3 | OXITRIL 30 MG COMPRIMIDOS GASTRORRESISTENTES | OXITRIL 30 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/24076IP3/24076IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29270 | MELYFARMA S.L. | 2026-01-09 | 1 | 1 | 1 | 2026-01-10 | 2026-01-09 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 769611 | 24077IP3 | OXITRIL 60 MG COMPRIMIDOS GASTRORRESISTENTES | OXITRIL 60 MG COMPRIMIDOS GASTRORRESISTENTES, 28 comprimidos | 60 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/24077IP3/24077IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29270 | MELYFARMA S.L. | 2026-01-09 | 1 | 1 | 1 | 2026-01-10 | 2026-01-09 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 769613 | 24077IP3 | OXITRIL 60 MG COMPRIMIDOS GASTRORRESISTENTES | OXITRIL 60 MG COMPRIMIDOS GASTRORRESISTENTES, 56 comprimidos | 60 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/24077IP3/24077IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29270 | MELYFARMA S.L. | 2026-01-09 | 1 | 1 | 1 | 2026-01-10 | 2026-01-09 | 1 | 2026-02-13 | View Edit Delete |
Page 25 of 1036, showing 20 records out of 20704 total, starting on record 481, ending on 500